INmune Bio Inc (INMB) stock has fallen 13.84% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With INMB Stock Today?
INmune Bio Inc (INMB) stock is higher by 5.45% while the S&P 500 is down -0.34% as of 9:57 AM on Friday, Jan 22. INMB is up $1.11 from the previous closing price of $20.36 on volume of 110,757 shares. Over the past year the S&P 500 is higher by 15.60% while INMB is up 308.95%. INMB lost -$0.97 per share in the over the last 12 months.
To see the top 5 stocks in the Biotechnology industry click here.
More About INmune Bio Inc
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. The company's pipeline products include INBO3, XPro1595, LIVNate, and others.
Click Here to get the full Stock Score Report on INmune Bio Inc (INMB) Stock.
